https://doi.org/10.4081/reumatismo.2016.873
New approved drugs for psoriatic arthritis
Submitted: 22 February 2016
Accepted: 13 July 2016
Published: 9 September 2016
Accepted: 13 July 2016
Abstract Views: 2864
PDF: 2130
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Perrotta, F., & Lubrano, E. (2016). New approved drugs for psoriatic arthritis. Reumatismo, 68(2), 57–64. https://doi.org/10.4081/reumatismo.2016.873
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- G. Pasero, P. Marson, short history of anti-rheumatic therapy. IV. Corticosteroids , Reumatismo: Vol. 62 No. 4 (2010)
- P. Lisi, DIFFERENTIAL DIAGNOSIS OF PSORIASIS , Reumatismo: Vol. 59 No. s1 (2007)
- P. Frallonardo, R. Ramonda, A. Lo Nigro, V. Modesti, C. Campana, L. Punzi, The natural history of ankylosing spondylitis in the 21st century , Reumatismo: Vol. 63 No. 1 (2011)
- G. Zampogna, R. Andracco, M. Parodi, M.A. Cimmino, Clinical features of gout in a cohort of Italian patients , Reumatismo: Vol. 61 No. 1 (2009)
- M.C. Leone, A. Alunno, G. Cafaro, V. Valentini, E. Marcucci, E. Bartoloni, R. Gerli, The clinical spectrum of primary Sjögren’s syndrome: beyond exocrine glands , Reumatismo: Vol. 69 No. 3 (2017)
- F. Almassinokiani, A. Mehdizadeh Kashi, A. Musavi, S. Khodaverdi, K. Tahermanesh, S. Ariana, Rectal perforation in a 42-year-old woman due to Henoch-Schönlein purpura: a case report , Reumatismo: Vol. 69 No. 3 (2017)
- M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni, Safety of rituximab in rheumatoid arthritis , Reumatismo: Vol. 62 No. 2 (2010)
- G. Pasero, P. Marson, A short history of anti-rheumatic therapy. I. An introduction on traditional and drug treatments , Reumatismo: Vol. 62 No. 1 (2010)
- C. Sales, F. Oliviero, P. Spinella, The mediterranean diet model in inflammatory rheumatic diseases , Reumatismo: Vol. 61 No. 1 (2009)
- M. Varenna, L. Sinigaglia, Adherence to treatment of osteoporosis: an open question , Reumatismo: Vol. 61 No. 1 (2009)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
You may also start an advanced similarity search for this article.
